Discover What's Driving the Next Wave of RNA-Targeted Drug Discovery
The RNA-targeted small molecule field is reaching a critical inflection point.
As more programs advance toward the clinic, pharma interest grows, and novel modalities emerge beyond splice modulation, understanding where the science is heading has never been more important.
Download the 2026 Event Guide to the 9th RNA-Targeted Drug Discovery & Development Summit to explore the companies, speakers, data, and scientific advances shaping the future of RNA-targeted therapeutics.
Inside the Event Guide
Need the guide sent directly to your inbox?
Contact the team and we'll be happy to send you a copy.
Get Your Complimentary Event Guide
Why 2026 Matters
The RNA-targeted small molecule field is evolving rapidly.
Recent years have seen:
- More clinical-stage programs
- Growing pharma investment and partnerships
- New modalities beyond splice modulation
- Expanding applications across oncology, rare disease, and neurodegeneration
- Increasing confidence in RNA as a druggable therapeutic target
Download the Event Guide to see how industry leaders are responding to this momentum.
Featured Organizations Include
And other leaders advancing RNA-targeted therapeutics from discovery to the clinic.
Bringing Colleagues?
Many organizations attend with teams spanning:
- Computational Biology/AI
- Biophysics
- RNA Biology
- Drug Discovery
- Medicinal Chemistry
- Structural Biology
- Chemical Biology
- Translational Research
- Pharmacology
- Screening & Assay Development
- Business Development
Download the guide to identify the sessions most relevant to your team or book on now:
